Source: FinSMEs

Vivace received $35M in Series D Funding

Followers on Owler

Est. Annual Revenue

$100K-5.0M

Est. Employees

1-25

President & CEO

Sofie Qiao

CEO Approval Rating

90/100

Vivace is a pharmaceutical company that develops and commercializes small molecule drugs for the treatment of cancer diseases.